Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia

EBioMedicine

Volumn 8, Issue , 2016, Pages 173-183

  Liu, Yuan Fang ^a   Wang, Bai Yan ^a,i   Zhang, Wei Na ^a   Huang, Jin Yan ^a   Li, Ben Shang ^c   Zhang, Ming ^a   Jiang, Lu ^a   Li, Jian Feng ^a   Wang, Ming Jie ^a   Dai, Yu Jun ^a   Zhang, Zi Guan ^b   Wang, Qiang ^a   Kong, Jie ^a   Chen, Bing ^a   Zhu, Yong Mei ^a   Weng, Xiang Qin ^a   Shen, Zhi Xiang ^a   Li, Jun Min ^a   Wang, Jin ^a   Yan, Xiao Jing ^f   Li, Yan ^f   Liang, Ying Min ^g   Liu, Li ^g   Chen, Xie Qun ^g   Zhang, Wang Gang ⁱ   Yan, Jin Song ^h   Hu, Jian Da ^j   Shen, Shu Hong ^c   Chen, Jing ^c   Gu, Long Jun ^c   Pei, Deqing ^e   Li, Yongjin ^e   Wu, Gang ^e   Zhou, Xin ^e   Ren, Rui Bao ^a   Cheng, Cheng ^e   Yang, Jun J ^e   Wang, Kan Kan ^a   Wang, Sheng Yue ^d   Zhang, Jinghui ^e   Mi, Jian Qing ^a   Pui, Ching Hon ^e   Tang, Jing Yan ^c   Chen, Zhu ^a,b   Chen, Sai Juan ^a,b   more..

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b Chinese National Human Genome Center at Shanghai   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

^e ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^f CHINA MEDICAL UNIVERSITY   (China)

^g FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^h DALIAN MEDICAL UNIVERSITY   (China)

ⁱ THE SECOND AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^j FUJIAN MEDICAL UNIVERSITY   (China)

more..

Author keywords

Adult B ALL; MEF2D fusions; Next generation sequencing; Pediatric B ALL; ZNF384 fusions

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BONE MARROW BIOPSY; CANCER INHIBITION; CELL DIFFERENTIATION; CHROMOSOME ANALYSIS; CLINICAL TRIAL; COPY NUMBER VARIATION; DNA REPAIR; DNA SEQUENCE; FEMALE; GENE DELETION; GENE EXPRESSION; GENE FUSION; GENE MUTATION; IMMUNOPHENOTYPING; LEUKEMOGENESIS; MALE; MOUSE; NEXT GENERATION SEQUENCING; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; ADOLESCENT; ADULT; AGED; BONE MARROW; CHILD; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GENOMICS; HIGH THROUGHPUT SEQUENCING; HUMAN; INFANT; MIDDLE AGED; MORTALITY; MUTATION; MUTATION RATE; PATHOLOGY; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRESCHOOL CHILD; PROCEDURES; PROGNOSIS; YOUNG ADULT;

ONCOPROTEIN; TRANSCRIPTOME;

ADOLESCENT; ADULT; AGED; BONE MARROW; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; DNA COPY NUMBER VARIATIONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INFANT; MIDDLE AGED; MUTATION; MUTATION RATE; ONCOGENE PROTEINS, FUSION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; TRANSCRIPTOME; YOUNG ADULT;

EID: 84969916695     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2016.04.038     Document Type: Article

References (33)

1. Adzhubei I.A., Schmidt S., Peshkin L., et al. A method and server for predicting damaging missense mutations. Nat. Methods 2010, 7:248-249.
2. Andersson A.K., Ma J., Wang J., et al. The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias. Nat. Genet. 2015, 47:330-337.
3. Bassan R., Hoelzer D. Modern therapy of acute lymphoblastic leukemia. J. Clin. Oncol. 2011, 29:532-543.
4. Chalandon Y., Thomas X., Hayette S., et al. Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia. Blood 2015, 125:3711-3719.
5. Chen B., Wang Y.-Y., Shen Y., et al. Newly diagnosed acute lymphoblastic leukemia in China (I): abnormal genetic patterns in 1346 childhood and adult cases and their comparison with the reports from Western countries. Leukemia 2012, 26:1608-1616.
6. Choi Y., Chan A.P. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics 2015, 31:2745-2747.
7. Chudnovsky Y., Kim D., Zheng S., et al. ZFHX4 interacts with the NuRD core member CHD4 and regulates the glioblastoma tumor-initiating cell state. Cell Rep. 2014, 6:313-324.
8. Cohen S., Shoshana O.-y., Zelman-Toister E., et al. The cytokine midkine and its receptor RPTPζ regulate B cell survival in a pathway induced by CD74. J. Immunol. 2012, 188:259-269.
9. Den Boer M.L., van Slegtenhorst M., De Menezes R.X., et al. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. Lancet Oncol. 2009, 10:125-134.
10. Gabriel A.S., Lafta F.M., Schwalbe E.C., et al. Epigenetic landscape correlates with genetic subtype but does not predict outcome in childhood acute lymphoblastic leukemia. Epigenetics 2015, 10:717-726.
11. Geng H., Hurtz C., Lenz K.B., et al. Self-enforcing feedback activation between BCL6 and pre-B cell receptor signaling defines a distinct subtype of acute lymphoblastic leukemia. Cancer Cell 2015, 27:409-425.
12. Gocho Y., Kiyokawa N., Ichikawa H., et al. A novel recurrent EP300-ZNF384 gene fusion in B-cell precursor acute lymphoblastic leukemia. Leukemia 2015, 29:2445-2448.
13. Greenman C., Stephens P., Smith R., et al. Patterns of somatic mutation in human cancer genomes. Nature 2007, 446:153-158.
14. Haberland M., Arnold M.A., McAnally J., Phan D., Kim Y., Olson E.N. Regulation of HDAC9 gene expression by MEF2 establishes a negative-feedback loop in the transcriptional circuitry of muscle differentiation. Mol. Cell. Biol. 2007, 27:518-525.
15. Haberland M., Montgomery R.L., Olson E.N. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat. Rev. Genet. 2008, 10:32-42.
16. Heavey B., Charalambous C., Cobaleda C., Busslinger M. Myeloid lineage switch of Pax5 mutant but not wild-type B cell progenitors by C/EBPalpha and GATA factors. EMBO J. 2003, 22:3887-3897.
17. Hirose J., Kouro T., Igarashi H., Yokota T., Sakaguchi N., Kincade P.W. A developing picture of lymphopoiesis in bone marrow. Immunol. Rev. 2002, 189:28-40.
18. Jabbour E., O'Brien S., Konopleva M., Kantarjian H. New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia. Cancer 2015, 121:2517-2528.
19. Ma X., Edmonson M., Yergeau D., et al. Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia. Nat. Commun. 2015, 6:6604.
20. Mi J.Q., Wang X., Yao Y., et al. Newly diagnosed acute lymphoblastic leukemia in China (II): prognosis related to genetic abnormalities in a series of 1091 cases. Leukemia 2012, 26:1507-1516.
21. Mullighan C.G., Goorha S., Radtke I., et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 2007, 446:758-764.
22. Mullighan C.G., Zhang J., Kasper L.H., et al. CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature 2011, 471:235-239.
23. Notta F., Zandi S., Takayama N., et al. Distinct routes of lineage development reshape the human blood hierarchy across ontogeny. Science 2016, 351:aab2116.
24. Opferman J.T., Letai A., Beard C., Sorcinelli M.D., Ong C.C., Korsmeyer S.J. Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature 2003, 426:671-676.
25. Prima V., Gore L., Caires A., et al. Cloning and functional characterization of MEF2D/DAZAP1 and DAZAP1/MEF2D fusion proteins created by a variant t(1;19)(q23;p13.3) in acute lymphoblastic leukemia. Leukemia 2005, 19:806-813.
26. Pui C.-H. PART XI: NEOPLASTIC LYMPHOID DISEASES, 93. Acute lymphoblastic leukemia. Williams Hematology. 2460 2010, McGraw-Hill Education, USA, (2010-07-09). eighth ed. M.L. Kenneth Kaushansky, E. Beutler, T. Kipps, J. Prchal, U. Seligsohn (Eds.).
27. Pui C.-H., Yang J.J., Hunger S.P., et al. Childhood acute lymphoblastic leukemia: progress through collaboration. J. Clin. Oncol. 2015, 33:2938-2948.
28. Roberts K.G., Morin R.D., Zhang J., et al. Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. Cancer Cell 2012, 22:153-166.
29. Roberts K.G., Li Y., Payne-Turner D., et al. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N. Engl. J. Med. 2014, 371:1005-1015.
30. Schultz K.R., Carroll A., Heerema N.A., et al. Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group study AALL0031. Leukemia 2014, 28:1467-1471.
31. Xiao H., Wang L.M., Luo Y., et al. Mutations in epigenetic regulators are involved in acute lymphoblastic leukemia relapse following allogeneic hematopoietic stem cell transplantation. Oncotarget 2016, 7:2696-2708.
32. Xie H., Ye M., Feng R., Graf T. Stepwise reprogramming of B cells into macrophages. Cell 2004, 117:663-676.
33. Yasuda T., Tsuzuki S., Kawazu M., et al. Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults. Nat. Genet. 2016, 48:569-574.